期刊
NATURE REVIEWS CANCER
卷 8, 期 5, 页码 351-360出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrc2373
关键词
-
类别
This Review deals with recent progress in the immunotherapy of established (pre) malignant disease of viral or non-viral origin by synthetic vaccines capable of inducing robust T-cell responses. The most attractive vaccine compounds are synthetic long peptides (SLP) corresponding to the sequence of tumour viral antigens or tumour-associated non-viral antigens. Crucial to induction of therapeutic T-cell immunity is the capacity of SLP to deliver specific cargo to professional antigen-presenting cells ( dendritic cells ( DC)). Proper DC activation then induces the therapeutic CD4(+) and CD8(+) T-cell responses that are associated with regression of established ( pre) malignant lesions, including those induced by high-risk human papilloma virus.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据